Role of growth hormone and sex steroids in achieving and maintaining normal bone mass

Hormone Research in Paediatrics

Volumn 45, Issue 1-2, 1996, Pages 86-93

  Holmes, Sarah J ^a   Shalet, Stephen M ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

Bone mass; Osteoporosis; Sex steroids

Indexed keywords

GROWTH HORMONE; SEX HORMONE; SOMATOMEDIN C;

BONE MASS; BONE TURNOVER; CONFERENCE PAPER; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; OSSIFICATION; OSTEOLYSIS; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL;

ADULT; ANDROGENS; ANIMALS; BONE DENSITY; BONE DEVELOPMENT; CHILD; ESTROGENS; FEMALE; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; OSTEOPOROSIS;

EID: 0030038975     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000184765     Document Type: Article

References (96)

1. Harris WH, Heaney RP: Effect of growth hormone on skeletal mass in adult dogs, Nature 1969:223:403-404.
2. Shore RM, Chesncy RW, Mazess RB, Rose PCI, Bargman GJ: Bone mineral status in growth hormone deficiency, J Pediatr 1980:96: 393-396.
3. Zamhoni G, Anloniazzi F, Radetti G, Musu-meci C, Tato L: Effects of two different regimens of recombinant human growth hormone therapy on the bone mineral density of patients with growth hormone deficiency, J Pe-dialr 1991;119:483-485.
4. Saggese G, Baroncelli GI, Bertclloni S, Cin-quanta L, Di Nero G: Effects of long-term treatment with growth hormone on bone and mineral metabolism in children with growth hormone deficiency, J Pediatr 1993:122: 37-45.
5. Cotnpston JE, Evans WD, Crawley EO, Evans C: Bone mineral content in normal UK subjects, BrJ Radio 1988:61:631-636.
6. Dcgerblad M, Almkvist O, Grunditz R, Hall K, Kaijscr L, Knutsson E, Ringertz H, Thoren M: Physical and psychological capabilities during substitution therapy with recombinant growth hormone in adults with growth hormone deficiency, Acta Endocrinol 1990;123:185-193.
7. Hyer SL, Rodin DA, Tobias JH, Leiper A, Ntts-sey SS: Growth hormone deficiency during puberty reduces adult bone mineral density, Arch Dis Child 1992:67:1472-1474.
8. Kaufman JM, Taelman P, Vermeulen A, Vandeweghe M: Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset, J Clin Endocrinol Metab 1992:74: 118-123.
9. Amato G, Carclla C, Fazio S, La Montagna G, Cittadini A, Sabatini D, Marciano-Mone C, Sacca L, Bcllastclla A: Body composition, bone metabolism, and heart structure and function in growth hormone (GH(-deficient adults before and after GH replacement therapy at low doses, J Clin Endocrinol Metab 1993:77: 1671-1676.
10. O'Halloran DJ, Tsatsoulis A, Whitchouse RW, Holmes SJ, Adams JE, Shalet SM: Increased bone density after recombinant human growth hormone (GH) therapy in adults w ith isolated GI I deficiency, J Clin Endocrinol Metab 1993; 76:1344-1348.
11. De Bier H, Blok GJ, Van Lingen A, Teule GJJ, Lips P, Van Der Veen EA: Consequences of childhood-onset growth hormone deficiency for adult bone mass, J Bone Miner Res 1994:9: 1319-1326.
12. Rosen T, Hansson T, Granhed H, Szucs J, Bcngtsson BA: Reduced bone mineral content in adult patients with growth hormone deficiency, Acta Endocrinol 1993:129:201-206.
13. Bing-You RG, Denis MC, Rosen CJ: Low bone mineral density in adults with previous hypo-thalamic-pituitary' tumors: Correlations with serum growth hormone responses to GH-relcasing hormone, insulin-like growth factor I, and IGF binding protein 3. Caleif Tissue hit 1993:52:183-187.
14. Holmes SJ, Economou G, Whitchouse RW, Adams JE, Shalet SM: Reduced bone mineral density in patients with adult onset growth hormone deficiency, J Clin Endocrinol Metab 1994:78:669-674.
15. Bonjour JP, Theintz, G, Buchs B, Slosman D, Rizzoli R: Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence, J Clin Endocrinol Metab 1991:73:555-563.
16. Theintz G, Buchs B, Rizzoli R, Slosman D, Clavien H, Sizonenko PC, Bonjour JP: Longitudinal monitoring of bone mass accumulation in healthy adolescents: Evidence fora marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects, J Clin Endocrinol Metab 1992:75: 1060-1065.
17. Hall ML, Heavens J, Cullum ID, Ell PJ: The range of bone density in normal British women, BrJ Radiol 1990:63:266-269.
18. Oil SM: Attainment of peak bone mass, J Clin Endocrinol Metab 1990:71:1082A-1082C
19. Binncrts A, Swart GR, Wilson JHP, Hoogcr-brugge N, Pols HAP, Birkenhager JC, Lamberts SWJ: The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as oil body composition, Clin Endocrinol 1992:37:79-87.
20. Vandeweghe M, Taelman P, Kaufman JM: Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone deficient males, Clin Endocrinol 1993:39:409-415.
21. Rosen T, Johannsson G, Hallgren P, Caidahl K, Bosacus I, Bengtsson BA: Beneficial effects of 12 months replacement therapy with recombinant human growth hormone to growth hormone deficient adults, Endocrinol Metab 1994; 1:55-66.
22. Stiegler C, Leb G: One year of replacement therapy in adults with growth hormone deficiency, Endocrinol Metab 1994; I (suppl A): 37-42.
23. Baum HBA, Biller BMK, Baker KE, Klibanski A: Physiologic growth hormone (GH) replacement improves body composition and bone density in men with adult-onset GH-defi-ciency, Proc 76th Meet Endocr Soc, 1994. p, 279.
24. Slootweg MC, van Buul-Offers SC, Herr-mann-Erlee MPM, Duursma SA: Direct stimulatory effect of growth hormone on DNA synthesis of fetal chicken osteoblasts in culture, Acta Endocrinol 1988:118:294-300.
25. Ernst M, Froesch ER: Growth hormone dependent stimulation of osteoblast-like cells in serum-free cultures via local synthesis of insulin-like growth factor I, Biochem Biophys Res Commun 1988:151:142-147.
26. Slootweg MC, Most WW, van Beek E, Schot LPC, Papapoulos SE, Lbwik CWGM: Osteoclast formation together with interleukin-6 production in mouse long bones is increased by insulin-like growth factor-1. J Endocrinol 1992:132:433-438.
27. Mochizuki H, Hakcda Y, Wakatsuki N, Usui N, Akashi S, Sato T, Tanaka K, Kumcgawa M: Insulin-like growth factor-1 supports formation and activation of osteoclasts, Endocrinology 1992:131:1075-1080.
28. Isaksson OGP, Jansson JO, Gause IAM: Growth hormone stimulates longitudinal bone growth directly, Science 1982:216: 1237-1239.
29. Russell SM, Spencer EM: Local injections of human or rat growth hormone or of purified human sontalomedin-C stimulate unilateral libial epiphyseal growth in hypophys-ectomized rats, Endocrinology 1985:116: 2563-2567.
30. Schlcchler NL, Russell SM, Spencer EM, Nicoll CS: Evidence suggesting that the direct growth-promoting effect of growth homione on cartilage in vivo is mediated by local production of somatomedin, Proc Natl Acad Sci USA 1986:83:7932-7934.
31. Schoenle E, Zapf J, Humbel RE, Froesch ER: Insulin-like growth factor I stimulates growth in hypophysectomized rats, Nature 1982:296: 252-253.
32. Johansen JS, Jensen SB, Riis BJ, Rasmussen L, Christiansen C: Serum bone gla protein: A potential marker of growth hormone (GH) deficiency and the response to GH therapy, J Clin Endocrinol Metab 1990;71:122-126.
33. Sartorio A, Conti A, Guzzatoni G, Faglia G: Serum osteocalcin levels in patients with GH deficiency before and during GH treatment, Acta Paediatr Scand 1991:80:100-102.
34. Johansen JS, Pedersen SA, Jorgensen JOL, Riis BJ, Christiansen C, Christiansen JS, Skakkeback NE: Effects of growth hormone (GH) on plasma bone gla protein in GH-defi-cient adults, J Clin Endocrinol Metab 1990:70: 916-919.
35. Schlemmer A, Johanson JS, Pedersen A, Jorgensen JOL, Hassager C, Christiansen C: The effect of growth hormone (GH) therapy on urinary pyridinoline cross-links in GH-deficient adults, Clin Endocrinol 1991:35:471-476.
36. Degerblad M, Elgindy N, Hall K, Sjbberg HE, Thoren M: Potent effect of recombinant growth hormone on hone mineral density and body composition in adults with panhypopituitarism, Acta Endocrinol 1992:126:387-393.
37. Johannsson G, Rosen T, Bosacus I, Hallgrcn P, Bcngtsson B A: The effects of 2 years treatment with recombinant human growth hormone (RHGH) in growth hormone deficient adults (GHDA), Endocrinol Metab 1994;1 (suppl B): 12.
38. Smith RW Jr.: Dietary and hormonal factors in bone loss, Fed Proc 1967:26:1737-1746.
39. lranmanesh A, Lizarralde G, Veldhuis JD: Age and relative adiposity are specific negative determinants of the frequency and amplitude of growth hormone (GH) secretory bursts and the half-life of endogenous GH in healthy men, J Clin Endocrinol Metab 1991:73:1081-1088.
40. Rudman D, Kutncr MIL Rogers CM, Lubin MF, Fleming GA, Bain RP: Impaired growth hormone secretion in the adult population, Relation to age and adiposity, J Clin Invest 1981; 67:1361-1369.
41. Franchimont P, Urbain-Choffray D, Lambelin P, Fontaine MA, Frangin G, Reginster JY: Effects of repetitive administration of growth hormone-releasing homione on growth hormone secretion, insulin-like growth factor I, and bone metabolism in postmenopausal women, Acta Endocrinol 1989:120:121-128.
42. Rico H, Del Rio A, Vila T, Patino R, Carrera F, Espinos D: The role of growth hormone in the pathogenesis of postmenopausal osteoporosis, Arch Intern Med 1979;139:1263-1265.
43. Dequeker J, Burssens A, Bouillon R: Dynamics of growth homione secretion in patients with osteoporosis and in patients with osteoarthrosis, Homi Res 1982:16:353-356.
44. Ljunghall S, Johansson AG, Bumian P, Kiimpe O, Lindli E, Karlsson FA: Low plasma levels of insulin-like growth factor I (IGF-I) in male patients with idiopathic osteoporosis, J Intern Med 1992:232:59-64.
45. Pun KK, Lau P, Wong FHW, Cheng CL, Pun WK, Chow SP, Leong JCY: 25-Hydroxy-cholecalciferol and insulin-like growth factor I are determinants of serum concentration of osteocalcin in elderly subjects with and without spinal fractures, Bone 1990; 11:397-400.
46. Bennett AE, Waliner HW, Riggs BL, Hintz, RL: Insulin-like growth factors I and II: Aging and bone density in women, J Clin Endocrinol Metab 1984:59:701-704.
47. Nicolas V, Prewell A, Bettica P, Mohan S, Fin-kelman RD, Baylink DJ, Farley JR: Age-related decreases in insulin-like growth factor-I and transforming growth factor-p in femoral cortical bone from both men and women: Implications for bone loss with aging, J Clin Endocrinol Metab 1994:78:1011-1016.
48. Kruse HP, Kuhlencordt F: Oil an attempt to treat primary and secondary osteoporosis with human growth hormone, Horm Metab Res 1975:7:488-491.
49. Aloia JF, Zanzi I, Ellis K, Jowsey J, Roginsky M, Wallaeh S, Cohn SH: Effects of growth hormone in osteoporosis, J Clin Endocrinol Metab 1976;43:992-999.
50. Aloia JF, Vaswani A, Kapoor A, Yeh JK, Cohn SH: Treatment of osteoporosis with calcitonin, with and without growth homione, Metabolism 1985:34:124-129.
51. Aloia JF, Vaswani A, Meunier PJ, Edouard CM, Allot ME, Yeh JK, Cohn SH: Coherence treatment of postmenopausal osteoporosis with growth homione and calcitonin, Calcil Tissue Int 1987:40:253-259.
52. Rudman D, Feller AG, Nagraj HS, Gergans GA, Lalitha PY, Goldberg AF, Schlenker RA, Cohn L, Rudman IW, Mattson DE: Effects of human growth hormone in men over 60 years old, N Engl J Med 1990:323:1-6.
53. I lolloway L, Butterfield G, Hint/RL, Gcsund-licit N, Marcus R: Effects of recombinant human growth hormone on metabolic indices, body composition, and bone turnover in healthy elderly women, J Clin Endocrinol Metab 1994:79:470-479.
54. Finkelstein JS, Neer RM, Biller BMK, Crawford JD, Klibanski A: Osteopenia in men with a history of delayed puberty, N Engl J Med 1992; 326:600-604
55. Finkelstein JS, Klibanski A, Neer RM, Greenspan SL, Rosenthal DI, Crowley WF: Osteoporosis in men with idiopathic hypogonado-tropic hypogonadism, Ann Intern Med 1987: 106:354-361.
56. Dhuper S, Warren MP, Brooks-Gunn J, Fox R: Effects of hormonal status on bone density in adolescent girls, J Clin Endocrinol Metab 1990:71:1083-1088.
57. Riggs BL, Melton LJ III: Involutional osteoporosis, N Engl J Med 1986:314:1676-1686.
58. Richclson LS, Wahner HW, Melton LJ III, Riggs BL: Relative contributions of aging and estrogen deficiency to postmenopausal bone loss, N Engl J Med 1984:311:1273-1275.
59. Klibanski A, Neer RM, Beilins IZ, Ridgway EC, Zervas NT, McArthur JW: Decreased bone density in hyperprolactinaemic women, N Engl J Med 1980:303:1511-1514.
60. Biller BMK, Baum HBA, Rosenthal DI, Saxe VC, Chalpic PM, Klibanski A: Progressive trabecular osteopenia in women with hyperpro-lactinaemic amenorrhoea, J Clin Endocrinol Metab 1992:75:692-697.
61. Drinkwater BL, Nilson K, Chesnut CLI III, Bremner WJ, Shainholtz S, Soulhworth MB: Bone mineral content of amenorrheic and eumenorrheic athletes, N Engl J Med 1984: 311:277-281.
62. Redman JR, Bajorunas DR, Wong G, McDermott K, Gneeco C, Schneider R, Lacher MJ, Lane JM: Bone mineralization in women following successful treatment of Hodgkin's disease, Am J Med 1988:85:65-72.
63. Krcuser ED, Felsenberg D, Bellies C, Seibt-Jung H, Mielcarek M, Diehl V, Dahmcn E, Thiel E: Long-term gonadal dysfunction and its impact on bone mineralization in patients following COPP/ABVD chemotherapy for Hodgkin's disease, Ann Oncol 1992:3 (suppl 4): 105-110.
64. Riggs BL, Mellon LJ III: Evidence fortwodistinct syndromes of involutional osteoporosis, Am J Med 1983:75:899-891.
65. Greenspan SI-, Ncer RM, Ridgway EC, Klibanski A: Osteoporosis in men with hyperpro-lactinucmic hypogonadism, Ann Intern Med 1986:104:777-782.
66. Horowitz M, Wisharl JM, Otoughlin PD, Morris HA, Need AG, Nordin BEC: Osteoporosis and Klinefeller’s syndrome, Clin Endocrinol 1992:36:113-118.
67. Ste pan JJ, Lachman M, Zverina J, Pacovsky V, Baylink DJ: Castrated men exhibit bone loss: Effect of calcitonin treatment on biochemical indices of bone remodeling, J Clin Endocrinol Metab 1989;69:523-527.
68. Holmes SJ, Whitchouse RW, Clark ST, Crow-ther DC, Adams JE, Shalet SM: Reduced bone mineral density in men following chemotherapy for Hodgkin's disease, Br J Cancer 1994: 70:371-375.
69. Goldray D, Weisman J, Jaecard N, Merdler C, Chen J, Matzkin H: Decreased bone density in elderly men treated with the gonadotropin-releasing hormone agonist decapeptyl (D-Trp"-GnRH), J Clin Endocrinol Metab 1993:76: 288-290.
70. Cummings SR, Black DM, Nevitt MC, Browner W, Cauley J, Ensrud K, Genant HK, Palermo L, Scott J, Vogt TM: Bone density at various sites for prediction of hip fractures, Lancet 1993:341:72-75.
71. Lindsay R, Hart DM, Ailken JM, MacDonald EB, Anderson JB, Clarke AC: Longterm prevention of postmenopausal osteoporosis by oestrogen, Lancet 1976;i: 1038-1041.
72. Stevenson JC, Cusl MP, Gangar KF, Hillard TC, Lees B, Whitehead MI: Effects of trans-dcrmal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women, Lancet 1990:336:265-269.
73. Ryde SJS, Bowen-Simpkins K, Bowen-Simp-kins P, Evans WD, Morgan WD, Compston JE: The effect of oestradiol implants on regional and total bone mass: A three-year longitudinal study, Clin Endocrinol 1994;40:33-38.
74. Hutchinson TA, Polansky SM, Feinstein AR: Post-menopausal oestrogens protect against fractures of hip and distal radius, Lancet 1979:ii:705-709.
75. Finkelslein JS, Klibanski A, Ncer RM, Doppelt SH, Rosenthal DI, Segre GV, Crowley WF Jr.: Increases in bon: density during treatment of men with idiopathic hypogonadotropic hypogonadism, J Clin Endocrinol Metab 1989:69: 776-783.
76. Longcope C: Adrenal and gonadal androgen secretion in normal females, Clin Endocrinol Metab 1986:15:213-228.
77. Orentreich N, Brind JL, Rizer RL, Vogclman JH: Age changes and sex differences in serum dehydroepiandrostcrone sulfate concentrations throughout adulthood, J Clin Endocrinol Metab 1984:59:551-555.
78. Klibanski A, Biller BMK, Rosenthal DI, Schoenfeld DA, Saxe V: Effects of prolactin and estrogen deficiency in amenorrheic bone loss, J Clin Endocrinol Metab 1988:67: 124-130.
79. Nordin BEC, Robertson A, Seamark RF, Bridges A, Philcox JC, Need AG, Horowitz M, Morris HA, Deam S: The relation between calcium absorption, serum dehydroepiandrostcrone, and vertebral mineral density in postmenopausal women, J Clin Endocrinol Metab 1985:60:651-657.
80. Marshall DH, Crilly RG, Nordin BEC: Plasma androstenedione and oestrone levels in normal and osteoporotic postmenopausal women, Br Med J 1977;ii: 1177-1179.
81. Buchanan JR, Ilospodar P, Myers C, Leuen-berger P, Centers LM: Effect of excess endogenous androgens on bone density in young women, J Clin Endocrinol Metab 1988:67: 937-943.
82. Devogclar JP, Crabbe J, Nagant de Dcuxchais-nes C: Bone mineral density in Addison's disease: Evidence for an effect of adrenal androgens on bone mass, Br Med J 1987:294: 798-800.
83. Mason HD, Martikainen H, Beard RW, Any-aoku V, Franks S: Direct gonadotrophic effect of growth hormone on oestradiol production by human granulosa cells in vitro, J Endocrinol 1990:126:R1-R4.
84. Bourguignon JP, Vandeweghe M, Vander-schueren-Lodeweyckx M, Malvaux P, Wolter R, Du Caju M, Ernould C: Pubertal growth and final height in hypopituitary boys: A minor role of bone age at onset of puberty, J Clin Endocrinol Metab 1986:63:376-382.
85. Rosenfeld RG, Roscnbloom AL, Guevara-Aguirre J: Growth hormone (GH) insensitivity due to primary GH receptor deficiency, Endocr Rev 1994:15:369-390.
86. Martha PM, Reiter ED: Pubertal growth and growth hormone secretion, Endocrinol Metab Clin North AM 1991:20:165-182.
87. Ho KY, Evans WS, Blizzard RM, Veldhuiws JD, Merriam GR, Samojlik E, Furlanetlo R, Rogol AD, Kaiser DL, Thomcr MO: Effects of sex and age on the 24-hour profile of growth hormone secretion in man: Importance of endogenous estradiol concentrations, J Clin Endocrinol Metab 1987:64:51-58.
88. Corpus E, Human SM, Pineyro MA, Roberson R, Blackman MR: Growth hormone (GH)-releasing hormone-!I-29) twice daily reverses the decreased GH and insulin-like growth factor-! levels in old men, J Clin Endocrinol Metab 1992:75:530-535.
89. Dawson-Hughes B, Stern D, Goldman J, Kcichlin S: Regulation of growth hormone and somalomedin-C secretion in postmenopausal women: Effect of physiological estrogen replacement, J Clin Endocrinol Metab 1986:63: 424-432.
90. Weissberger AJ, Ho KKY, Lazarus L: Contrasting effects of oral and transdcrmal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women, J Clin Endocrinol Metab 1991:72:374-381.
91. 9 Rosenfield RL, Furlanetto RW: Physiologic testosterone or estradiol induction of puberty increases plasma somatomedin-C, J Pediatr 1985:107:415-417.
92. Liu L, Merriam GR, Sherins RJ: Chronic sex steroid exposure increases mean plasma growth hormone concentration and pulse amplitude in men with isolated hypogonadotropic hypogonadism, J Clin Endocrinol Metab 1987; 64:651-656.
93. Ogilvy-Stuart AL, Clayton PE, Shalet SM: Cranial irradiation and early puberty, J Clin Endocrinol Metab 1994:78:1282-1286.
94. Mann DR, Rudman CG, Akinbami MA, Gould KA: Preservation of bone mass in hypogo-nadal female monkeys with recombinant human growth hormone administration, J Clin Endocrinol Metab 1992:74:1263-1269.
95. Mora S, Weber G, Guarncri MP, Nizzoli G, Pasolini D, Chiumello G: Effect of estrogen replacement therapy on bone mineral content in girls with Turner syndrome, Obstet Gynecol 1992.79:747-751.
96. Neely FK, Marcus R, Rosenfeld RG, Bachrach LK: Turner syndrome adolescents receiving growih hormone are not osteopenic, J Clin Endocrinol Metab 1993:76:861-866.